COST-EFFECTIVENESS OF HLA-B*1502 GENOTYPING IN ADULT PATIENTS WITH NEWLY DIAGNOSED EPILEPSY IN SINGAPORE

被引：5
|
作者：
Hung, Shuen-Iu
Chung, Wen-Hung
机构：
来源：
NEUROLOGY | 2013年 / 80卷 / 17期
关键词：
D O I：
10.1212/WNL.0b013e3182915be2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1621 / 1621
页数：1
相关论文
共 50 条
  • [21] Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand
    Tiamkao, Somsak
    Jitpimolmard, Jukrapope
    Sawanyawisuth, Kittisak
    Jitpimolmard, Suthipun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (04) : 608 - 612
  • [22] Phenytoin safety questioned for HLA-B*1502-positive patients
    [J]. Reactions Weekly, 2008, 1230 (1) : 4 - 4
  • [23] A Markov model of treatment of newly diagnosed epilepsy in the UKAn initial assessment of cost-effectiveness of topiramate
    E. Remák
    J. Hutton
    M. Price
    K. Peeters
    I. Adriaenssen
    [J]. The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (4): : 271 - 278
  • [24] Pharmacogenomics screening of HLA-B*1502 in epilepsy patients: How we do it in the UKM Medical Centre, Malaysia
    Then, Sue-Mian
    Rani, Zam Zureena Mohd
    Raymond, Azman Ali
    Jamal, Rahman
    [J]. NEUROLOGY ASIA, 2013, 18 : 27 - 29
  • [25] Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV plus patients in Spain
    Nieves Calatrava, Diana
    de la Calle-Martin, Oscar
    Iribarren-Loyarte, Jose A.
    Rivero-Roman, Antonio
    Garcia-Bujalance, Laura
    Perez-Escolano, Isabel
    Brosa-Riestra, Max
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (09): : 590 - 595
  • [26] The Cost-Effectiveness of "Getting to Goal" in Patients with Newly Diagnosed Type 2 Diabetes
    Willis, Michael
    Asseberg, Christian
    He, Jianming
    Neslusan, Cheryl
    [J]. DIABETES, 2009, 58 : A45 - A45
  • [27] THE COST-EFFECTIVENESS OF TUMOR-TREATING FIELDS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Armoiry, X.
    Auguste, P.
    Dussart, C.
    Guyotat, J.
    Connock, M.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 68 - 68
  • [28] Cost-effectiveness analysis of laboratory monitoring in newly diagnosed telogen effluvium patients
    Miller, Rhiannon C.
    Curtis, Kaya L.
    Abedian, Sajjad
    Lipner, Shari R.
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (07)
  • [29] HLA-B*15:02 screening in epilepsy not cost effective
    [J]. Reactions Weekly, 2016, 1591 (1) : 10 - 10
  • [30] The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
    Schackman, Bruce R.
    Scott, Callie A.
    Walensky, Rochelle P.
    Losina, Elena
    Freedberg, Kenneth A.
    Sax, Paul E.
    [J]. AIDS, 2008, 22 (15) : 2025 - 2033
12345